$STOK 4/A SEC Filings

Filed On	Filing
10 Dec 2024	Form 4/A: Kaye Edward M. Md, Director Received 26,250 shares by exercise or conversion · Granted 52,500 Performance Stock Units
26 May 2020	Form 4/A: Liau Gene, EVP Research & Preclinical Dev Exercised 6,000 Employee Stock Option (right to buy) · Exercised 7,500 Employee Stock Option (right to buy)
26 May 2020	Form 4/A: Kaye Edward M. Md, Director Exercised 50,000 Employee Stock Option (right to buy)

Comments